Stay ConnectedFrom the ground floor to the C-Suite, Building Biotechs offers a behind-the-scenes look into the strategy that goes into launching and scaling successful biotech and life science companies.
We talk with biotech executives, founders, HR leaders, and culture builders to learn how they think about growing companies with intention, and discuss the valuable lessons they’ve learned along the way.
Copyright: Copyrights © 2023 All Rights Reserved by Recruitomics Consulting
This week I had a great conversation with Russ Peloquin, Managing Partner of LifeSci Catalyst Partners. We dive into Russ's unique journey from aspiring exterminator (yes, you read that right!) to leading life science entrepreneur, discussing his extensive experience in commercialization, mergers, and acquisitions. Russ shares invaluable insights on the importance of marketing, fundraising strategies for biotech startups, the phases of taking a company from idea to commercialization, and the critical steps toward securing regulatory approvals. We also touch on the intersection of genome sequencing, blockchain, and AI, exploring how this convergence is set to democratize and capitalize on personal DNA. Whether you're new to biotech or an industry veteran, this episode offers a wealth of knowledge and practical advice on navigating the complex landscape of life sciences and startups.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction and Early Aspirations
02:04 Journey into Medical Sales
03:37 Marketing and Commercialization Insights
05:31 Navigating Early-Stage Startups
08:39 Fundraising Strategies for Biotech Startups
15:00 Acquisitions and Exits
22:39 The Intersection of Genome Sequencing, Blockchain, and AI
29:49 Future Goals and Recommendations
31:47 Closing Remarks and Contact Information
This week I chatted with Renee Williams, Founder and Managing Partner at Williams Biotech Consulting. Renee is a seasoned fractional Chief Business Officer (CBO) for small and growing biotechnology companies. Renee shares her career path, insights into helping biotech startups secure funding and navigate partnerships, and the importance of adaptable strategies in a constantly evolving market. From term sheet negotiation to pitch deck reframes, Renee offers valuable advice and lessons for small companies. We also dissect her engagement tactics during major conferences like JP Morgan and the essential factors for biotech success.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction and Childhood Dreams
01:19 The Power of Dressing the Part
01:49 Career Path and Consulting Firm
03:20 Role of a Fractional CBO
04:03 Navigating Startup Challenges
06:07 Crafting Effective Pitch Decks
08:32 Big Pharma vs. Biotech Mentality
16:01 The Importance of a Strong Team in Biotech
16:20 Approaching Pharma and Corporate Venture Capital
17:20 Strategies for Biotech Companies to Gain Traction
18:24 Types of Biotech CEOs and Their Approaches
21:02 Navigating Conferences and Networking
27:09 Future Goals and Aspirations
28:59 Book Recommendations and Closing Thoughts
This week, I spoke with Natalie Nairn, co-founder and CEO of Cyclera Therapeutics. Natalie is also a Termeer Fellow, and listeners of this podcast know how much I love the Termeer Foundation. We discuss her transition from chemical engineering to biomedical applications. She describes her unexpected path into the fun and volatile startup space, which led to her founding Cyclera. Natalie explains the importance of focusing in biotech development, the promising applications of Cyclera's technology in CNS therapeutics, and the challenges and opportunities in the current funding landscape. She also highlights the value of the Termeer fellowship in her career, the contrast between Boston and Seattle's biotech scenes, and the essential aspects of leadership and team cohesion. Finally, Natalie discusses her future goals for Cyclera and offers valuable advice for aspiring biotech founders.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction and Early Aspirations
00:33 Journey into Biomedical Engineering
01:19 First Startup Experience
03:40 Founding Cyclera
05:02 Focus on CNS Therapeutics
13:35 Challenges and Strategies in Biotech
15:39 The Termeer Foundation Fellowship
21:26 Biotech Networks: Boston vs. Seattle
26:50 Future of Cyclera and Personalized Medicine
32:45 Conclusion and Final Thoughts
In this episode, I had an engaging conversation with Stacie Frye, co-founder and Chief Commercial Officer of StimulusBio, a life sciences commercialization and venture studio for biotech startups. We discussed how StimulusBio aids startups in operational and commercialization aspects, leveraging Stacie's unique journey across marketing, chemical engineering, and her experience with successful biotech exits. Experience from previous startups profoundly informs StimulusBio’s approach to helping startups transition from incubation to market. We explored the critical stages of startup growth, emphasizing the importance of marketing, storytelling, team building, and experience-based advice. Stacie also shared her insights into the emerging trends in the biotech industry, particularly in Houston's growing biotech ecosystem, and the importance of balancing innovation with practical business needs.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction to Stacie Frye and StimulusBio
00:51 Stacie's Unique Career Path
01:56 Early Career and Transition to Bioengineering
03:32 Startup Experiences and Lessons Learned
08:46 Challenges in Transitioning from Incubator to Market
12:44 The Importance of Marketing and Team Building
32:17 Emerging Trends and Future Goals
37:09 Conclusion and Contact Information
This week, I had an insightful conversation with David Sans, PhD, FAARM, MBA, who heads healthcare investment banking at EF Hutton. We discussed the intricacies of different Public Offering strategies, including micro IPOs, which offer a unique avenue for biotech companies. David provides a deep perspective on the strategic implications of IPOs for biotech funding. He emphasized the importance of investor support and strategic banking partnerships, especially for micro IPOs. We also discussed the potential of AI in reshaping financial services and the future of outcome-based pricing models in investment. David's personal insights reveal the demanding yet rewarding nature of investment banking and highlight crucial aspects to consider for those pursuing a career in this field.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction to Biotech and Investment Banking
00:48 David Sands' Background and Career Journey
02:12 Transition from Biotech to Finance
04:53 Understanding Micro IPOs
06:37 Challenges and Strategies in Biotech IPOs
16:38 The Role of the FDA in Biotech IPOs
18:30 Understanding IPO Disparities
18:42 Key Factors for a Successful IPO
19:29 Aftermarket Support and Investor Relations
20:59 The Role of Long-Term Investors
21:34 Personal Investment Strategies
22:29 Innovations in Financial Services
24:40 Challenges for Biotech CEOs
26:32 Career Path in Investment Banking
28:50 Future of Financial Services and AI
33:37 Book Recommendations and Closing Thoughts
This week I had a great conversation with Iva Toudjarska, founder and CEO of Zeal Therapeutics. From earning a PhD in molecular biology to a solid scientific career at Alnylam, to working in venture capital, to selling a successful SaaS company, Iva’s career that’s set her up well to enjoy this new challenge – founding a baby biotech. Her expertise marries business development, venture capital, and company-building. Iva shared valuable advice for biotech founders on securing funding, making strategic decisions, and building effective partnerships. Tune in to hear her experiences, lessons learned, and her current work leading Zeal Therapeutics, a precision kidney RNA therapeutics company.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 - Intro to Iva Toudjarska's Career
00:48 - Career overview, Iva Toudjarska, Zeal Therapeutics
04:26 - Successful biotech strategies, industry insights
07:02 - Building successful partnerships, collaboration tips
12:15 - Angel investing, funding strategies, biotech financing
20:20 - Leveraging background, skills for biotech success
24:38 - Setbacks in biotech, lessons learned, resilience
27:20 - Bootstrapping a company, startup funding, entrepreneurship
28:23 - Support for Eva, mentorship, biotech advice
29:18 - Future goals, biotech vision, 10-year plan
30:45 - Current reading, professional development, industry literature
24:24 Lessons Learned and Future Goals
28:08 Conclusion and Final Thoughts
This week I had a fun conversation with Jason Cordeiro, Chief Operating and Innovation Officer at MassBio. We dissect MassBio's newly announced five-year strategic plan that includes a multi-pronged set of initiatives aimed at advancing the biotech industry. From supporting early-stage startups to advocating for policy changes and fostering talent development, Jason details the excellent resources available and in development. Whether you're based in Massachusetts or global, this session provides valuable information on how MassBio is working to catalyze innovation and growth in biotech, and how you can leverage these opportunities.
00:00 - Intro
01:24 - Jason Cordeiro, MassBio’s COO
02:48 - What is MassBio
05:54 - MassBio’s MassCONNECT Program
08:15 - MassCONNECT Support for Non-Local Companies
13:15 - How to Get Involved in MassBio
17:24 - Next Level One Initiative
19:58 - MassBio Align Summit Overview
21:40 - Educating Investors through MassBio
27:11 - MassBio Pharma Days Event
31:00 - The Link Program
34:54 - MassBio’s 5-Year Strategic Plan
41:14 - Connecting with MassBio Resources
42:11 - Outro
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
In this episode, we revisit a fun conversation with Mike LaRhette, Chief Business Officer at LabCentral. Mike outlines the essentials for startups, including funding, lab space, mentorship, and resources. He shares his journey from aspiring architect to an architect of biotech ecosystems, detailing his experiences with MassChallenge and LabCentral. Mike offers insights into the key elements that make thriving ecosystems, like government support, industry collaboration, and a density of entrepreneurs. He also discusses how LabCentral supports startups through challenging markets, diverse talent acquisition, and successful graduations. The episode concludes with a lighthearted look at LabCentral's unique culture and the balance between hard work and fun.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction and Episode Overview
00:49 Meet Mike LaRhette: From Architect Aspirations to Ecosystem Builder
01:59 Journey into the Biotech Sector
04:34 A Day in the Life at LabCentral
07:32 The Human Side of Biotech Entrepreneurship
09:55 LabCentral Ignite: Bridging Talent and Opportunity
12:08 Effective Communication Strategies at LabCentral
18:13 Key Elements of a Successful Ecosystem
24:30 Debunking Myths About Entrepreneurs
25:58 Challenges in Post-COVID Event Engagement
26:58 Navigating the Tight Market
28:35 Golden Tickets Program
30:40 Support for New Founders at LabCentral
33:16 Transitioning Out of LabCentral
36:22 Balancing Fun and Seriousness at LabCentral
40:00 Future Directions and Personal Growth
41:49 Favorite Books and Final Thoughts
This week I spoke with Bogdan Knezevic, founder of Kaleidoscope Bio, about optimizing biotech workflows and achieving milestones efficiently. Bogdan shared insights into how his platform helps companies manage research and development processes, reducing operational inefficiencies and saving time, resources, and money. He discussed the importance of setting clear goals, breaking down complex workflows, and avoiding shiny object syndrome (a common ailment among scientists). Bogdan also emphasized the value of keeping teams focused and aligned, leveraging automation, and integrating existing tools to minimize manual work. We explored how to empower teams, balance short-term and long-term goals, and pivot gracefully when needed. Additionally, Bogdan touched on the importance of understanding the true cost of operations and making strategic investments in tools that drive productivity.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction to Systems and Workflow
01:10 Meet Bogdan Knezevic: From Childhood Dreams to Biotech CEO
02:22 The Frustration and Vision Behind Kaleidoscope Bio
04:01 Use Cases and Value Propositions for Biotech Companies
07:50 Empowering Teams and Setting Priorities
11:38 Balancing Short-Term and Long-Term Goals
18:22 Reducing Operational Overhead and Streamlining Processes
31:07 Common Mistakes and Lessons for Biotech Leaders
36:19 Book Recommendations and Closing Thoughts
This week I spoke with Jon Hu, CEO and co-founder of Pepper Bio, about his journey from pharma consulting and venture capital to founding a tech-enabled biotech company. Pepper Bio created an AI and machine learning platform accelerating drug discovery for untreatable diseases. In addition to the platform, Pepper is currently navigating their asset for liver cancer into phase 2 clinical trials. Jon highlighted the differences between tech and biotech, emphasizing the importance of dreaming big and aligning vision with employees. He shared insights on the importance of hiring, learning to learn, and overcoming challenges in transitioning from tech-enabled discovery to drug development. We also discussed Pepper Bio's computational platform, long-term strategy, and their Series A fundraising to support their clinical trial efforts. Jon’s personal story of family health challenges driving his passion for biotech underscored the company's mission to transform patient care.
Connect with us!
Subscribe here:
Learn more about Recruitomics Consulting
Check out our reading list
Download our free startup resources guide to grow your biotech efficiently
If you're on the job market, visit the Collaboratory Career Hub
00:00 Introduction to John Hu and Pepper Bio
00:54 John's Early Aspirations and Career Path
02:27 Founding Pepper Bio and Its Mission
05:15 Tech vs. Biotech: Ambitions and Challenges
10:42 Project Optimist and Pepper's Role
11:53 Pepper's Computational Platform and Future Goals
16:14 Navigating the Biotech Industry and Hiring Strategies
33:35 Personal Motivations and Future Aspirations
36:03 Book Recommendations and Closing Remarks
Our TOPPODCAST Picks 
